Intraoperative Radiation Therapy Delivered by Brachytherapy in Breast Cancer: An Interim Analysis of a Phase 2 Trial

CONCLUSION: Acknowledging the short median follow-up time at interim analysis, our initial results indicate that delivering IORT through HDR brachytherapy in carefully selected breast cancer patients is feasible and oncological safe so far. A long-term follow-up is essential to confirm the initial results.PMID:38185607 | DOI:10.1016/j.clbc.2023.12.006

Source: Clinical Genitourinary Cancer - January 7, 2024 Category: Cancer & Oncology Authors: Åsa Wickberg Clara Prag Antonis Valachis Leif Karlsson Bengt Johansson Source Type: research